Drug profile · INN
efanesoctocog alfa
ALTUVOCT
efanesoctocog alfa (ALTUVOCT) is a coagulation factor viii exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — efanesoctocog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
efanesoctocog alfa (ALTUVOCT) is a coagulation factor viii exogenous protein.
Key facts
INN efanesoctocog alfa
Brand ALTUVOCT
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is efanesoctocog alfa?
efanesoctocog alfa (ALTUVOCT) is a coagulation factor viii exogenous protein.
What is the brand name for efanesoctocog alfa?
ALTUVOCT is a marketed brand name for efanesoctocog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.